Document Detail

Additive value of torsion to global longitudinal left ventricular strain in patients with reduced ejection fraction.
MedLine Citation:
PMID:  22032049     Owner:  NLM     Status:  In-Process    
BACKGROUND: Torsional and longitudinal deformations are essential components of left ventricular (LV) performance. A precise assessment of LV function must take into account both LV torsion (LVtor) and global longitudinal strain (LVE). We compared a new 2D-strain parameter, LVtor x LVE, with several other echocardiographic parameters, with respect to their strength of association with N-terminal pro-brain natriuretic peptide (NTproBNP) in patients with reduced LV ejection fraction (LVEF).
METHODS: Echocardiography was performed simultaneously with NTproBNP determination in 78 consecutive patients with reduced LVEF (<50%) in sinus rhythm. Early diastolic transmitral velocity/early mitral annular diastolic velocity ratio (E/E') and systolic mitral annular velocity (S') were measured. LVtor was defined as the ratio between LV twist (LVtw) and LV end-diastolic longitudinal length. LVtw (net difference between rotation angles at base and apex) was obtained from parasternal apical and basal short-axis planes. LVE was obtained by averaging longitudinal peak systolic strain of all 17 LV-segments (from apical planes).
RESULTS: Log-transformed NTproBNP correlated significantly with LVE (r = 0.57, P < 0.001), myocardial performance index (r = 0.56, P < 0.001), systolic pulmonary artery pressure (r = 0.47, P < 0.001), E/E' (r = 0.41, P < 0.001), LVtor (r = -0.37, P = 0.001), E-velocity deceleration time (r = -0.37, P = 0.003), S' (r = -0.36, P = 0.002), LVtw (r = -0.34, P = 0.003), LVEF (r = -0.34, P = 0.003), E/A (A = late diastolic transmitral velocity, r = 0.30, P = 0.01) and E (r = 0.28, P = 0.03). LVtor x LVepsilon had the strongest correlation with log-NTproBNP (r = 0.70, P < 0.001). LVtor x LVepsilon was a better predictor of NTproBNP > 900 pg/ml (sensitivity = 82%, specificity = 84%) than other investigated parameters (each P < 0.05).
CONCLUSIONS: In patients with reduced LVEF, LVtor x LVE is a promising parameter that deserves research to establish its clinical meaning and prognostic value.
Cristian Mornos; Dan Ruşinaru; Adina Ionac; Lucian Petrescu; Dragoş Cozma; Sorin Pescariu; Stefan Iosif Drăgulescu
Related Documents :
6248799 - Stimulation by adrenaline and dopamine but not by noradrenaline of myocardial alpha-adr...
21425059 - Detection of valve malfunction after mechanical mvr using digital phonocardiography.
22560269 - A case of spontaneous coronary artery dissection: it is not always plaque rupture.
21786089 - Cardiac involvement in wegener's granulomatosis resistant to induction therapy.
22186969 - Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing c...
22154089 - Effect of hurricane katrina on incidence of acute myocardial infarction in new orleans ...
17939329 - Percutaneous coronary intervention versus coronary artery bypass grafting in patients w...
20948689 - Coma due to cardiac arrest: prognosis and contemporary treatment.
22411359 - Cost-effectiveness of cytochrome p450 2c19 genotype screening for selection of antiplat...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta cardiologica     Volume:  66     ISSN:  0001-5385     ISO Abbreviation:  Acta Cardiol     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370570     Medline TA:  Acta Cardiol     Country:  Belgium    
Other Details:
Languages:  eng     Pagination:  565-72     Citation Subset:  IM    
Cardiology Clinic, Institute of Cardiovascular Diseases, Timişoara, Romania.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Two souls in one breast--a case report of the rock star double.
Next Document:  CArdiac resynchronization in combination with beta blocker treatment in advanced chronic heart failu...